Fort Washington Investment Advisors Inc. OH Has $21.67 Million Position in Chemed Co. (NYSE:CHE)

Fort Washington Investment Advisors Inc. OH boosted its holdings in Chemed Co. (NYSE:CHE - Free Report) by 36.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 40,898 shares of the company's stock after buying an additional 11,020 shares during the period. Fort Washington Investment Advisors Inc. OH owned approximately 0.27% of Chemed worth $21,668,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Dimensional Fund Advisors LP grew its position in shares of Chemed by 19.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 153,957 shares of the company's stock worth $83,536,000 after buying an additional 24,721 shares during the period. Mercer Global Advisors Inc. ADV grew its holdings in Chemed by 4.7% during the second quarter. Mercer Global Advisors Inc. ADV now owns 1,545 shares of the company's stock valued at $838,000 after purchasing an additional 70 shares during the period. Intech Investment Management LLC increased its stake in Chemed by 62.7% in the second quarter. Intech Investment Management LLC now owns 610 shares of the company's stock valued at $331,000 after purchasing an additional 235 shares in the last quarter. Canada Pension Plan Investment Board bought a new stake in shares of Chemed in the second quarter valued at about $2,116,000. Finally, Pacer Advisors Inc. boosted its position in shares of Chemed by 4.4% during the second quarter. Pacer Advisors Inc. now owns 3,407 shares of the company's stock worth $1,849,000 after buying an additional 144 shares during the period. 95.85% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms recently weighed in on CHE. Royal Bank of Canada decreased their target price on shares of Chemed from $697.00 to $633.00 and set an "outperform" rating for the company in a research note on Tuesday, November 5th. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Saturday, November 30th.

Chemed Stock Down 1.5 %

Shares of Chemed stock traded down $8.34 on Thursday, hitting $542.80. The stock had a trading volume of 115,202 shares, compared to its average volume of 85,920. The stock has a market cap of $8.17 billion, a price-to-earnings ratio of 27.43, a price-to-earnings-growth ratio of 2.18 and a beta of 0.47. The business's 50 day moving average is $544.80 and its two-hundred day moving average is $563.00. Chemed Co. has a twelve month low of $512.12 and a twelve month high of $654.62.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 earnings per share for the quarter, missing the consensus estimate of $5.76 by ($0.12). The firm had revenue of $606.18 million for the quarter, compared to the consensus estimate of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $5.32 EPS. As a group, equities analysts predict that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.37%. Chemed's payout ratio is presently 10.11%.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares in the company, valued at $58,270,755.95. This represents a 1.93 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, VP Brian C. Judkins bought 145 shares of the company's stock in a transaction dated Monday, December 30th. The stock was purchased at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the transaction, the vice president now directly owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The disclosure for this purchase can be found here. Insiders own 3.32% of the company's stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.